Status:
RECRUITING
An in Vivo CT Imaging Study of GMA-Tulip, I-gel, and LMA Supreme (GLAM-II)
Lead Sponsor:
Zhejiang Cancer Hospital
Conditions:
Supraglottic Airway Device
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Laryngeal masks are core devices for supraglottic airway management, and the accuracy of their anatomical position directly impacts ventilation safety and the incidence of complications. Despite their...
Detailed Description
After approval by the Ethics Committee of Zhejiang Cancer Hospital (Approval Number: IRB-2025-001 (IIT)), this study will be registered on ClinicalTrials.gov prior to participant enrollment. Written i...
Eligibility Criteria
Inclusion
- Aged 18-75 years, scheduled for CT interventional therapy;
- Aged 18-75 years, scheduled for CT interventional therapy;
- Body Mass Index (BMI) \<30 kg/m²;
- Good communication and cooperation, with voluntary signing of the informed consent form.
Exclusion
- Presence of head/neck or airway anatomical abnormalities (e.g., laryngeal cartilage malformation, Grade III tonsillar hypertrophy, tongue hypertrophy, cervical spine malformation) that may affect laryngeal mask insertion or CT imaging evaluation;
- Current participation in other clinical studies.
Key Trial Info
Start Date :
October 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT07196696
Start Date
October 12 2025
End Date
December 31 2025
Last Update
November 25 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ethics Committee of Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China, 310022
2
Jiangling Wang
Hangzhou, Zhejiang, China, 310022